Collagen'Tile' Delivers Postsurgical Radiation in Glioblastoma Collagen'Tile' Delivers Postsurgical Radiation in Glioblastoma
Following tumor removal, an absorbable collagen tile delivers a controlled and therapeutic dose of radiation targeting remaining tumor cells and sparing healthy tissue, new research suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 6, 2022 Category: Cancer & Oncology Tags: Neurology & Neurosurgery News Source Type: news

COVID Booster Mounts'Brisk' Response in Patients With Cancer COVID Booster Mounts'Brisk' Response in Patients With Cancer
New data highlight the potential protective effect of primary COVID vaccination and boosters for patients with cancer undergoing therapy or who received stem cell transplant.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 6, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Clinical Chest Images Improve Survival Prediction in Lung Cancer Clinical Chest Images Improve Survival Prediction in Lung Cancer
A new study suggests that combining clinical and imaging features can help predict overall survival in early-stage disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 6, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer
With a standard approval from the FDA, the HER2-directed antibody drug conjugate can now be used earlier in treatment to delay disease progression.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Promising Antitumor Activity After One ADC Dose in Breast Cancer Promising Antitumor Activity After One ADC Dose in Breast Cancer
Early data suggest that the antibody drug conjugate patritumab deruxtecan increases antitumor activity in early-stage breast cancer after a single dose.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' No Discernible Benefit' Adding Nivolumab to ADC in Breast Cancer'No Discernible Benefit' Adding Nivolumab to ADC in Breast Cancer
However, combining nivolumab with trastuzumab deruxtecan in advanced, pretreated breast cancer did demonstrate antitumor activity, new data show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Unprecedented Crisis': Hodgkin Drug Shortage Persists'Unprecedented Crisis': Hodgkin Drug Shortage Persists
In a recent review, researchers went back decades to find the best alternative treatment for patients with advanced classical Hodgkin lymphoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Young Cancer Survivors May Face Education, Job Difficulties Young Cancer Survivors May Face Education, Job Difficulties
An international group encourages physicians to be aware of potential educational and employment issues and details recommendations to evaluate and monitor this population.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Does Not Approve TKI Surufatinib for Neuroendocrine Tumors FDA Does Not Approve TKI Surufatinib for Neuroendocrine Tumors
Drug manufacturer Hutchmed said the FDA sent the company a complete response letter indicating that the agency requires a multiregional clinical trial before approving the drug in the US.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Substantial Toxic Effects of Breast Radiotherapy Often Missed Substantial Toxic Effects of Breast Radiotherapy Often Missed
Substantial Toxic Effects of Breast Radiotherapy Often MissedMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Guideline on Diagnosis, Treatment of Rare GI Syndromes New Guideline on Diagnosis, Treatment of Rare GI Syndromes
The US Multi-Society Task Force on Colorectal Cancer provides 14 recommendations for the genetic evaluation, surveillance, and treatment of gastrointestinal hamartomatous polyposis syndromes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 29, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Liquid Biopsy in HCC: Valuable Tool for Detection, Monitoring Liquid Biopsy in HCC: Valuable Tool for Detection, Monitoring
Further research is needed, though, to overcome barriers to the routine clinical use of liquid biopsy for patients with hepatocellular carcinoma (HCC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 29, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

What Explains'Sobering' Variations in Breast Cancer Care? What Explains'Sobering' Variations in Breast Cancer Care?
Kathy Miller discusses results from a recent study illustrating the impact of geography on breast cancer care.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Tenure: A System Built on Coercion Tenure: A System Built on Coercion
Academic medicine depends on us giving away our labor for free. Why do we keep doing it?Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

Fifth COVID Shot Recommended for Patients With Cancer Fifth COVID Shot Recommended for Patients With Cancer
The National Comprehensive Cancer Network says those who are immunocompromised should get a second mRNA boaster against COVID.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news